Operating Margin in % of Ovid Therapeutics Inc. from 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Ovid Therapeutics Inc. quarterly/annual Operating Margin history and change rate from 2021 to Q3 2025.
  • Ovid Therapeutics Inc. Operating Margin for the quarter ending September 30, 2025 was -618 %, a 94.4% increase year-over-year.
  • Ovid Therapeutics Inc. annual Operating Margin for 2024 was -10.9K %, a 27.7% increase from 2023.
  • Ovid Therapeutics Inc. annual Operating Margin for 2023 was -15.1K %, a 309% decline from 2022.
  • Ovid Therapeutics Inc. annual Operating Margin for 2022 was -3.7K %, a 6301% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Ovid Therapeutics Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -618 +10.4K +94.4% Jul 1, 2025 Sep 30, 2025
Q2 2025 -625 +11.4K +94.8% Apr 1, 2025 Jun 30, 2025
Q1 2025 -10.4K +2.63K +20.2% Jan 1, 2025 Mar 31, 2025
Q4 2024 -10.9K +4.19K +27.7% Oct 1, 2024 Dec 31, 2024
Q3 2024 -11K +7.01K +39% Jul 1, 2024 Sep 30, 2024
Q2 2024 -12K +15.2K +56% Apr 1, 2024 Jun 30, 2024
Q1 2024 -13K +30.9K +70.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -15.1K -11.4K -309% Oct 1, 2023 Dec 31, 2023
Q3 2023 -18K Jul 1, 2023 Sep 30, 2023
Q2 2023 -27.2K Apr 1, 2023 Jun 30, 2023
Q1 2023 -43.9K Jan 1, 2023 Mar 31, 2023
Q4 2022 -3.7K Oct 1, 2022 Dec 31, 2022

Ovid Therapeutics Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -10.9K +4.19K +27.7% Jan 1, 2024 Dec 31, 2024
2023 -15.1K -11.4K -309% Jan 1, 2023 Dec 31, 2023
2022 -3.7K -3.76K -6301% Jan 1, 2022 Dec 31, 2022
2021 59.6 Jan 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.